A Case for Norepinephrine versus Octreotide and Midodrine in Hepatorenal Syndrome

被引：0
|
作者：
Anong, John [1 ]
Litchfield, John [2 ]
Reddy, Chakradhar [2 ]
Borthwick, Thomas [2 ]
机构：
[1] E Tennessee State Univ, Dept Internal Med, Johnson City, TN 37614 USA
[2] E Tennessee State Univ, Dept Gastroenterol, Johnson City, TN 37614 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-00402
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
402
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [21] EpoprostenolHepatorenal syndrome (first report) treated with midodrine and octreotide: case report
    Reactions Weekly, 2007, 1140 (1) : 10 - 10
  • [22] Combination Treatment With Octreotide, Midodrine, and Albumin Improves Survival in Patients With Type 1 and Type 2 Hepatorenal Syndrome
    Skagen, Catherine
    Einstein, Michael
    Lucey, Michael R.
    Said, Adnan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (07) : 680 - 685
  • [23] MEAN ARTERIAL PRESSURE AS AN INDEPENDENT PREDICTOR OF RESPONSE TO THERAPY WITH OCTREOTIDE, MIDODRINE, AND ALBUMIN IN PATIENTS WITH CIRRHOSIS AND HEPATORENAL SYNDROME
    Brown, Patrick R.
    Lenhart, Adrienne
    Khan, Omar
    Alimirah, Maryam
    Abdulla, Hafsa
    Salgia, Reena
    Uduman, Junior
    GASTROENTEROLOGY, 2018, 154 (06) : S1182 - S1182
  • [24] Combination treatment with octreotide, midodrine and albumin improves survival and renal function in patients with Hepatorenal syndrome: A large cohort study
    Said, Adrian
    Skagen, Catherine
    Einstein, Michael
    Lucey, Michael
    GASTROENTEROLOGY, 2006, 130 (04) : A806 - A806
  • [25] Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: A case-control study
    Alessandria, C.
    Debernardi-Venon, W.
    Carello, M.
    Ceretto, S.
    Rizzetto, A.
    Marzano, A.
    DIGESTIVE AND LIVER DISEASE, 2009, 41 (04) : 298 - 302
  • [26] Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: A case-control study
    Alessandria, C.
    Debernardi-Venon, W.
    Todros, L.
    Rizzetto, M.
    Marzano, A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S89 - S90
  • [27] EFFICACY OF MIDODRINE AND OCTREOTIDE (MIDO/OCTR) ON THE OUTCOME OF TYPE 1 HEPATORENAL SYNDROME (HRS-1) AT A UNIVERSITY TRANSPLANT CENTER
    Karim, Yasmin K.
    Liu, Eashen M.
    Lewis, James H.
    HEPATOLOGY, 2008, 48 (04) : 1068A - 1068A
  • [28] Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine
    Hoeldtke, Robert D.
    Bryner, Kimberly D.
    Hoeldtke, Martin E.
    Hobbs, Gerald
    CLINICAL AUTONOMIC RESEARCH, 2006, 16 (06) : 390 - 395
  • [29] Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine
    Robert D. Hoeldtke
    Kimberly D. Bryner
    Martin E. Hoeldtke
    Gerald Hobbs
    Clinical Autonomic Research, 2006, 16 : 390 - 395
  • [30] Successful therapy of hepatorenal syndrome with norepinephrine
    Pehl, C
    Schepp, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2000, 38 (12): : 945 - 950
12345